Information Links
Mims
Main Navigation
Drugs
Conditions
ArticlesGuidelines & Clinical Updates
Mirtazapine no more effective than placebo as an additive antidepressant
Mirtazapine is unlikely to provide any clinical benefit...
Pharmacists may be able to alter GP prescriptions in the event of a no-deal Brexit
Pharmacists may need emergency powers to amend prescriptions...
Benzodiazepines and Z drugs linked to risk of Alzheimer's disease
Use of benzodiazepines and related drugs is associated...
NICE updates chronic heart failure guideline
NICE has updated its guideline on chronic heart failure...
Free MIMS diabetes workshops - last few places remaining
Join MIMS at the 'Type 2 diabetes: getting to the heart...
Prescribing guidance 'not being followed' in older people with reduced kidney function
Prescribing recommendations are not being applied to...
Gabapentin and pregabalin to be subject to tighter controls
From April 2019 gabapentin and pregabalin will be reclassified...
Use of quinolone antibiotics should be restricted, says EMA
The European Medicines Agency (EMA) has recommended...
Are you up to date with the latest inhalers?
View images and key features of inhalers and other...
Antidepressant withdrawal 'much greater problem than guidelines suggest'
The incidence, severity and duration of antidepressant...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
